Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial
采用 (90)Y-clivatuzumab tetraxetan 和低剂量吉西他滨进行分次放射免疫治疗对晚期胰腺癌有效:一项 I 期试验
期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.27592
Ocean, Allyson J; Pennington, Kenneth L; Guarino, Michael J; Sheikh, Arif; Bekaii-Saab, Tanios; Serafini, Aldo N; Lee, Daniel; Sung, Max W; Gulec, Seza A; Goldsmith, Stanley J; Manzone, Timothy; Holt, Michael; O'Neil, Bert H; Hall, Nathan; Montero, Alberto J; Kauh, John; Gold, David V; Horne, Heather; Wegener, William A; Goldenberg, David M